bioRxiv · 10.1101/2020.05.16.099325
CATA: a comprehensive chromatin accessibility database for cancer
Abstract
Chromatin accessibility is a crucial epigenetic concept that plays a biological role in oncology. As humans become more involved in cancer research, a comprehensive database is required to identify and annotate tumor chromatin accessible regions (CARs). Here, CATA was developed to provide cancer-related CAR annotation. Currently, CATA possesses 2,991,163 CARs, relevant clinical data, and transcription factor binding predictions for cancer CARs from 410 tumor samples of 24 cancer types. Furthermore, CARs were annotated by SNPs, risk SNPs, eQTLs, linkage disequilibrium SNPs, transcription factors, CNV, SNV, enhancer, and 450K methylation sites in our database. By combining all these resources, we believe that CATA will provide better service for researchers on oncology. Our database is accessible at http://bio.licpathway.net/cata/Competing Interest StatementThe authors have declared no competing interest.View Full Text
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
zhou, J., Li, X., Qian, F., Xie, J., Li, C.. 2020-05-17. CATA: a comprehensive chromatin accessibility database for cancer. https://doi.org/10.1101/2020.05.16.099325
Cite the original work for its findings. Save a collection to share your selection of sources.